Fully automated synthesis procedure of 4-[18F]fluorobenzaldehyde by commercial synthesizer: amino-oxi peptide labelling prosthetic group(429 views) Speranza A, Ortosecco G, Castaldi E, Nardelli A, Pace L, Salvatore M
IBB-CNR, Edificio 10, Via Pansini 5, Napoli, Italy. antonio.speranza@hotmail.com
Dipartimento di Scienze Biomorfologiche e Funzionali, Università degli Studi di Napoli Federico II, Edificio 10, Via Pansini 5, Napoli, Italy
References: Bergmann, R., Scheunemann, M., Heichert, C., Biodistribution and catabolism of 18F-labelled neurotensin (8-13) analogs (2002) Nucl. Med. Biol., 29, pp. 61-7
Berndt, M., Pietzsch, J., Wuest, F., Labeling of low-density lipoproteins using the 18F-labeled thiol-reactive reagent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide (2007) Nucl. Med. Biol., 34, pp. 5-15
Bruus-Jensen, K., Poethko, T., Schottelius, M., Hauser, A., Schwaiger, M., Wester, H.J., Chemoselective hydrazone formation between HYNIC-functionalized peptides and 18F-fluorinated aldehydes (2006) Nucl. Med. Biol., 33, pp. 173-183
Fredriksson, A., Ekberg, K., Ingvar, M., Johansson, B.L., Wahren, J., Stone-Elander, S., In vivo biodistribution and pharmacokinetics of 18F-labeled human C-peptide: evaluation in monkeys using positron emission tomography (2002) Life Sci., 71, pp. 1361-1370
Haubner, R., Wester, H.J., Weber, W.A., Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography (2001) Cancer Res., 61, pp. 1781-1785
Iwata, R., Pascali, C., Bogni, A., A new convenient method for the preparation of 4-[18F]fluorobenzylhalides (2000) Appl. Radiat. Isot., 52, pp. 87-92
Katounina, T., Besret, L., Dhilly, M., Petit-Tabouè, M.C., Barbelivien, A., Baron, J.C., Dauphin, F., Barrè, L., Synthesis and biological investigation of [18F]MR18445, a 5-HT3 receptor partial agonist (1998) Bioorg. Med. Chem., 6, pp. 789-795
Lee, Y.S., Jeong, J.M., Kim, H.W., Chang, Y.S., Kim, Y.J., Hong, M.K., Rai, G.B., Suh, Y.G., An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK) (2006) Nucl. Med. Biol., 33, pp. 677-683
Lemaire, C., Damhaut, P., Plenevaux, A., Comar, D., Enantioselective synthesis of 6-[fluorine-18]-fluoro-l-dopa from no-carrier-added fluorine-18-fluoride (1997) J. Nucl. Med., 35, pp. 1996-2002
Mading, P., Fuchter, F., Wust, F., Module-assisted synthesis of the bifunctional labelling agent N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) (2005) Appl. Radiat. Isot., 63, pp. 329-332
Marik, J., Sutcliffe, L.J., Fully automated preparation of n.c.a. 4-[18F]fluorobenzoic acid and N-succinimidyl 4-[18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU) (2007) Appl. Radiat. Isot., 65, pp. 199-203
Okarvi, S.M., Recent progress in fluorine-18 labelled peptide radiopharmaceuticals (2001) Eur. J. Nucl. Med., 28, pp. 929-938
Schildan, A., Patt, M., Sabri, O., Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380) (2007) Appl. Radiat. Isot., 65, pp. 1244-1248
Stöcklin, G.L., Is there a future for clinical fluorine-18 radiopharmaceuticals (excluding FDG)? (1998) Eur. J. Nucl. Med., 25, pp. 1612-1616
Stöcklin, G., Wester, H.J., Strategies for radioligand development: Peptides for tumor targeting (1998) Positron Emission Tomography: A Critical Assessment of Recent Trends, pp. 57-90. , Gulyas, B, Müller-Gärtner, H.W, Eds, Kluwer Academic, Dordrecht, The Netherlands, pp
Toyokuni, T., Walsh, J.S., Dominguez, A., Phelps, M.E., Barrio, J.R., Gambhir, S.S., Satyamurthy, N., Synthesis of a new heterobifunctional linker, N-[4-(aminooxy)butyl]maleimide, for facile access to a thiol-reactive 18F-labeling agent (2003) Bioconjugate Chem., 14 (6), pp. 1253-1259
Lee, Y. S., Jeong, J. M., Kim, H. W., Chang, Y. S., Kim, Y. J., Hong, M. K., Rai, G. B., Suh, Y. G., An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c (RGDyK) (2006) Nucl. Med. Biol., 33, pp. 677-683
Okarvi, S. M., Recent progress in fluorine-18 labelled peptide radiopharmaceuticals (2001) Eur. J. Nucl. Med., 28, pp. 929-938
St cklin, G. L., Is there a future for clinical fluorine-18 radiopharmaceuticals (excluding FDG)? (1998) Eur. J. Nucl. Med., 25, pp. 1612-1616
St cklin, G., Wester, H. J., Strategies for radioligand development: Peptides for tumor targeting (1998) Positron Emission Tomography: A Critical Assessment of Recent Trends, pp. 57-90. , Gulyas, B, M ller-G rtner, H. W, Eds, Kluwer Academic, Dordrecht, The Netherlands, pp
Fully automated synthesis procedure of 4-[18F]fluorobenzaldehyde by commercial synthesizer: amino-oxi peptide labelling prosthetic group